Warren Wasiewski, MD
Senior Scientific Advisor
Warren Wasiewski, MD, serves as Senior Scientific Advisor at NeuroTrauma Sciences. He is a board-certified pediatric neurologist with more than 20 years of clinical experience in pediatric neurology and more than 15 years of experience in the pharmaceutical industry. His pharmaceutical experience includes drug development across all phases of clinical advancement, establishing global regulatory strategies, assessing business development opportunities and mergers, and raising capital to support clinical programs. Most recently, Warren was Chief Medical Officer and Vice President of Research and Development for Bioblast Pharma, a clinical-stage biotechnology company focused on rare diseases. Prior to that, he was Chief Medical Officer and Executive Vice President of Clinical Development for Neurotrope BioScience, leading its Alzheimer’s disease program as well as two pipeline programs in orphan indications. Previously, he was Vice President of Clinical Development for Neurology at Alexion Pharmaceuticals and, earlier, Senior Medical Director for AstraZeneca in Neurology. Warren’s clinical career includes both academic and private practice, as an Associate Professor of Pediatrics at Penn State Children’s Hospital and Chair of Pediatrics at Lancaster General Hospital. Warren received a B.A. from Rutgers College, an M.S. from State University of New York Downstate Medical Center, and an M.D. from State University of New York, Buffalo.